Is A a good stock to buy? We came across a bullish thesis on Agilent Technologies, Inc. on Quality At A Fair Price’s Substack. In this article, we will summarize the bulls’ thesis on A. Agilent Technologies, Inc.’s share was trading at $120.96 as of April 20th. A’s trailing and forward P/E were 26.70 and 20.37, respectively according to Yahoo Finance.
VILevi/Shutterstock.com
Agilent Technologies, Inc. is a global leader in life sciences, diagnostics, and applied chemical markets, having operated as an independent company since its spin-off from Hewlett-Packard in 1999. Despite its strong positioning, the stock currently offers a relatively modest dividend yield of 0.84%, slightly above its five-year average of 0.69%, implying a potential valuation discount of around 18%.
Read More: 15 AI Stocks That Are Quietly Making Investors Rich
Read More: Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential
However, dividend growth has decelerated in recent years, averaging just over 5% across the past three years, which may be underwhelming for income-focused investors—especially given that the company’s payout ratio has remained conservatively below 20% over the past five years, suggesting ample room for higher distributions.
From a total return perspective, Agilent presents a more compelling picture. The company is expected to deliver a forward annual return of approximately 13.44%, supported by three key components: the current dividend yield contributing 0.84%, a 3.44% uplift from a potential reversion to fair value, and robust earnings growth projected at above 9%.
This combination highlights a balanced investment case where capital appreciation, rather than income, plays the dominant role. While the slower pace of dividend increases may limit its appeal to dividend growth investors, the company’s disciplined capital allocation, low payout ratio, and consistent earnings expansion provide a solid foundation for long-term value creation. Overall, Agilent appears attractively positioned for investors seeking steady growth with modest income, particularly if valuation normalization materializes.
Previously, we covered a bullish thesis on Agilent Technologies, Inc. (A) by YZ and TJ Terwilliger in September 2024, which highlighted the company’s strong market positioning, recurring revenue model, stable growth, and upside potential from its pharmaceutical API business. A’s stock price has depreciated by approximately 14.78% since our coverage. Quality At A Fair Price shares a similar view but emphasizes on dividend profile, valuation discount, and total return potential driven by earnings growth and re-rating.
Agilent Technologies, Inc. is not on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 71 hedge fund portfolios held A at the end of the fourth quarter which was 53 in the previous quarter. While we acknowledge the risk and potential of A as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than A and that has 10,000% upside potential, check out our report about this cheapest AI stock.
Disclosure: None.
